BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9500984)

  • 1. Src homology-2 domains protect phosphotyrosyl residues against enzymatic dephosphorylation.
    Brunati AM; Pinna LA; Bergantino E; Ruzzene M; Cirri P; Ramponi G; Donella-Deana A
    Biochem Biophys Res Commun; 1998 Feb; 243(3):700-5. PubMed ID: 9500984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antennapedia/HS1 chimeric phosphotyrosyl peptide: conformational properties, binding capability to c-Fgr SH2 domain and cell permeability.
    Ruzza P; Donella-Deana A; Calderan A; Brunati A; Massimino ML; Elardo S; Mattiazzo A; Pinna LA; Borin G
    Biopolymers; 2001; 60(4):290-306. PubMed ID: 11774232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the phosphotyrosyl phosphatase specificity of protein phosphatase type 2A and phosphotyrosyl phosphatase type 1B using phosphopeptides and the phosphoproteins p50/HS1, c-Fgr and Lyn.
    Agostinis P; Donella-Deana A; Van Hoof C; Cesaro L; Brunati AM; Ruzzene M; Merlevede W; Pinna LA; Goris J
    Eur J Biochem; 1996 Mar; 236(2):548-57. PubMed ID: 8612628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SH2 domains mediate the sequential phosphorylation of HS1 protein by p72syk and Src-related protein tyrosine kinases.
    Ruzzene M; Brunati AM; Marin O; Donella-Deana A; Pinna LA
    Biochemistry; 1996 Apr; 35(16):5327-32. PubMed ID: 8611520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic studies on full length and the catalytic domain of the tandem SH2 domain-containing protein tyrosine phosphatase: analysis of phosphoenzyme levels and Vmax stimulatory effects of glycerol and of a phosphotyrosyl peptide ligand.
    Wang J; Walsh CT
    Biochemistry; 1997 Mar; 36(10):2993-9. PubMed ID: 9062130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
    Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase.
    Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC
    J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
    Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
    Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidyl aldehydes as reversible covalent inhibitors of SRC homology 2 domains.
    Park J; Fu H; Pei D
    Biochemistry; 2003 May; 42(17):5159-67. PubMed ID: 12718560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific stimulation of c-Fgr kinase by tyrosine-phosphorylated (poly)peptides--possible implication in the sequential mode of protein phosphorylation.
    Ruzzene M; Brunati AM; Donella-Deana A; Marin O; Pinna LA
    Eur J Biochem; 1997 May; 245(3):701-7. PubMed ID: 9183008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S
    J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S.
    MacLean D; Sefler AM; Zhu G; Decker SJ; Saltiel AR; Singh J; McNamara D; Dobrusin EM; Sawyer TK
    Protein Sci; 1995 Jan; 4(1):13-20. PubMed ID: 7773170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
    Ellis C; Kasmi F; Ganju P; Walls E; Panayotou G; Reith AD
    Oncogene; 1996 Apr; 12(8):1727-36. PubMed ID: 8622893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.